SHINE Technologies, a pioneering fusion technology company, was founded in 2010 by Dr. Greg Piefer, a University of Wisconsin alumnus and Emeritus Board of Visitors Member. The company grew out of federally funded research conducted at UW-Madison. Unlike other fusion technology companies, SHINE focuses on commercializing fusion technology through a phased approach. Initially, SHINE technologies used neutrons from fusion technology to support aerospace and defense industries, including the U.S. military.
Currently, SHINE is advancing into its second phase by utilizing isotope generators to produce medical isotopes, like lutetium-177 which is used in targeted cancer treatments. Historically, a significant portion of lutetium-177 production relied on materials sourced from Russia; SHINE aims to become the world’s first vertically integrated manufacturer of lutetium-177.